Ignite Creation Date:
2024-05-06 @ 7:01 PM
Last Modification Date:
2024-10-26 @ 2:58 PM
Study NCT ID:
NCT05863104
Status:
COMPLETED
Last Update Posted:
2024-04-04
First Post:
2023-04-27
Brief Title:
Assessment of Safety Tolerability Systemic Exposure and Efficacy of GPB Cream in Adolescents With Severe Primary Hyperhidrosis
Sponsor:
Dr August Wolff GmbH Co KG Arzneimittel
Organization:
Dr August Wolff GmbH Co KG Arzneimittel
Study Overview
Official Title:
An Open-label Uncontrolled Multicenter Study to Evaluate the Safety Local Tolerability Systemic Exposure and Efficacy of 1 Glycopyrronium Bromide GPB Cream in Adolescents With Severe Primary Axillary Hyperhidrosis
Status:
COMPLETED
Status Verified Date:
2024-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
The aim of this study is to evaluate the safety tolerability and systemic exposure in a subset of patients of topical administration of 1 GPB in adolescents with severe primary axillary hyperhidrosis
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None